On the role of interleukin 36 in host defense against Mycobacterium tuberculosis:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Abschlussarbeit Buch |
Sprache: | English |
Veröffentlicht: |
Berlin
2017
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | 127 Seiten Illustrationen, Diagramme |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV044426105 | ||
003 | DE-604 | ||
005 | 20220628 | ||
007 | t | ||
008 | 170726s2017 a||| m||| 00||| eng d | ||
035 | |a (OCoLC)1013468798 | ||
035 | |a (DE-599)BVBBV044426105 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-11 | ||
084 | |a YE 1604 |0 (DE-625)153370:12910 |2 rvk | ||
100 | 1 | |a Ahsan, Fadhil |d 1985- |e Verfasser |0 (DE-588)1137384514 |4 aut | |
245 | 1 | 0 | |a On the role of interleukin 36 in host defense against Mycobacterium tuberculosis |c von Fadhil Ahsan |
264 | 1 | |a Berlin |c 2017 | |
300 | |a 127 Seiten |b Illustrationen, Diagramme | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
502 | |b Dissertation |c Humboldt-Universität zu Berlin |d 2017 | ||
655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
776 | 0 | 8 | |i Reproduziert als |a Ahsan, Fadhil |t On the role of interleukin 36 in host defense against Mycobacterium tuberculosis |d Ketsch bei Mannheim : Mikroform Dissertation, 2017 |h 2 Mikrofiches |w (DE-604)BV044868753 |
856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029827593&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-029827593 |
Datensatz im Suchindex
_version_ | 1804177724725526528 |
---|---|
adam_text | LIST OF CONTENTS
ABSTRACT..........................................................................................................................
8
ZUSAMMENFASSUNG.......................................................................................................9
INTRODUCTION................................................................................................................
11
1. MYCOBACTERIUM TUBERCULOSIS (MTB)
...........................................................................11
1.1. GLOBAL PERSPECTIVE ON
TUBERCULOSIS........................................................................11
1.2. GENERAL FEATURES OF THE
PATHOGEN........................................................................13
1.3. CELL ENVELOPE STRUCTURE
..........................................................................................
14
2. HOST INNATE IM M UNITY TO M TB
.....................................................................................
16
2.1. MACROPHAGE AS ONE OF THE MAJOR INNATE
CELLS...................................................... 16
2.1.1. ALVEOLAR
MACROPHAGE....................................................................................
16
2.1.2. ACTIVATION OF MACROPHAGE AND ANTIBACTERIAL EFFECTORS
.................................
17
2.2. SENSING MTB: ROLE OF TLRS AND OTHER
RECEPTORS................................................... 18
2.3. ROLE OF EFFECTOR PROTEINS: ANTIMICROBIAL PEPTIDES AND CYTOKINES
..........................
21
2.3.1. ANTIMICROBIAL
PEPTIDES...................................................................................21
2.3.2. THE MAIN CYTOKINES: TNF, IFNY AND
IL-1.....................................................22
3. INTERLEUKIN 36 AS THE FAM ILY MEMBER OF IL -1
............................................................23
3.1. OVERVIEW OF IL-1 FAM
ILY..........................................................................................
23
3.1.1. EXPRESSION PATTERN AND PROTEOLYTIC PROCESSING
...........................................
26
3.1.2. SIGNALING CASCADE AND IMMUNE
EFFECTORS.....................................................27
3.2. STRUCTURE AND EXPRESSION OF IL-36
CYTOKINES.........................................................27
3.3. IL-36 RECEPTOR AND DOWNSTREAM
SIGNALING.............................................................
29
4. LIVER X RECEPTOR
(LXR)..............................................................................................
30
4.1. EXPRESSION AND ACTIVATION OF LXR
.........................................................................
30
4.2. REGULATION OF HOST
CHOLESTEROL...............................................................................31
4.3. ROLE OF LXR IN
TUBERCULOSIS...................................................................................32
AIM OF THE PRESENT
STUDY.......................................................................................
33
MATERIALS AND
METHODS..........................................................................................
34
1.
MATERIALS.......................................................................................................................
34
2. HUMAN PRIM ARY CELLS AND CELL LIN E S
.........................................................................
34
3. M ICE
.....................................................................
34
4. B
ACTERIA.........................................................................................................................35
5. V IRU S
..............................................................................................................................35
6.
METHODS........................................................................................................................35
6.1. CELL
CULTURES...........................................................................................................
35
6.1.1. HUMAN CELL CULTURE AND MACROPHAGE
DIFFERENTIATION...................................35
6.1.2. MURINE BONE MARROW ISOLATION AND MACROPHAGE
DIFFERENTIATION.................36
6.2. BACTERIAL CULTURE AND IN VITRO
INFECTION..................................................................37
6.3. ASSESSMENT OF GENE
EXPRESSION...........................................................................37
6.3.1. RNA
EXTRACTION...............................................................................................37
6.3.2. REVERSE TRANSCRIPTION AND REAL TIME QUANTITATIVE PCR
(QPCR)..................37
6.4. ENZYME-LINKED IMMUNOSORBENT ASSAY
(ELISA)...................................................38
6.5. WESTERN BLOT
ANALYSIS.............................................................................................38
6.6. GENERATION OF GENETICALLY MODIFIED THP-1
CELLS...................................................39
6.6.1. LENTIVIRUS
PRODUCTION.....................................................................................
39
6.6.2. LENTIVIRUS TRANSDUCTION AND CELL
SELECTION....................................................39
6.7. ISOLATION OF MYCOBACTERIAL GENOMIC DMA AND R N A
............................................
40
6.6. CELL
STIMULATIONS.....................................................................................................
41
6.9. ENDOTOXIN
ASSESSMENT..........................................................................................
41
6.10. CELL VIABILITY
ASSESSMENT.....................................................................................
42
6.10.1. CYTOTOXICITY
ASSAY.......................................................................................
42
6.10.2. MTS VIABILITY
ASSAY.....................................................................................
42
6.11. IN SILICO CLEAVAGE SITE
PREDICTION..........................................................................42
6.12. ASSESSMENT OF BACTERIAL
REPLICATION.....................................................................43
6.12.1. [3H]-URACIL UPTAKE
ASSAY............................................................................43
6.12.2. COLONY FORMING UNIT
ASSAY..........................................................................43
6.13. LUCIFERASE
ASSAY..................................................................................................44
6.14. IN SILICO PREDICTION OF TRANSCRIPTION FACTOR BINDING
SITES......................................44
6.15. ASSESSMENT OF
CHOLESTEROL..................................................................................
44
6.15.1. CHOLESTEROL/ CHOLESTERYL ESTER QUANTIFICATION
.............................................
44
6.15.2. FILIPIN III FREE CHOLESTEROL STAINING
..............................................................
44
6.15.3. CHOLESTEROL
EFFLUX........................................................................................
44
6.16. STATISTICAL
ANALYSIS................................................................................................45
RESULTS............................................................................................................................
46
1. REGULATION OF IL-36 EXPRESSION UPON MTB INFECTION
..............................................
46
1.1. IL-36Y EXPRESSION UPON MTB INFECTION
..................................................................
46
1.2. MYD88-TLR2/4-DEPENDENT IL-36Y PRODUCTION UPON MTB INFECTION
....................
46
1.3. MTB LIPOPROTEINS/LIPOGLYCANS AND HEAT SHOCK PROTEINS
INDUCE IL-36Y UP-REGULATION VIA TLR2 AND TLR 4
...............................................
50
1.4. CASPASE-1 AND INFLAMMASOME CONTRIBUTE TO AMPLIFICATION OF
IL-36Y.................52
1.5. IL-1 SS AND IL-18 ARE SUFFICIENT FOR CASPASE/INFLAMMASOME-DEPENDENT
INDUCTION OF
IL-36Y.................................................................................................53
1.6. IL-1R1 AND IL-18R1 ARE ESSENTIAL FOR LATE-STAGE
AMPLIFICATION OF IL-36Y
LEVELS.................................................................................57
2. 11,-36 SIGNALING MODULATES MACROPHAGE HOST DEFENSE AGAINST M TB
.................59
2.1. IL-36 SIGNALING INHIBITS MTB GROWTH
......................................................................
59
2.2. IL-36 MEDIATES ANTIMICROBIAL PEPTIDE PRODUCTION
................................................
61
2.3. IL-36 SIGNALING FACILITATES LXR ACTIVATION UPON MTB INFECTION
.............................
63
2.4. RECOMBINANT IL-36Y FACILITATES THE PRODUCTION OF
ENDOGENOUS LXR
LIGANDS.......................................................................................
66
2.5. IL-36-INDUCED HOST DEFENSE IN MACROPHAGE IS
LXR-DEPENDENT........................66
2.6. IL-36/LXR AXIS CONTRIBUTES TO CHOLESTEROL METABOLISM
........................................
73
2.7. SUPPRESSION OF INTRACELLULAR CHOLESTEROL SYNTHESIS REDUCES MTB
GROWTH
............
77
DISCUSSION.....................................................................................................................
80
1. MAIN FINDINGS O F THE PRESENT S TU D Y
......................................................................
80
2. REGULATION O F IL-36 EXPRESSION UPON INFECTION AND STIM ULATION
BY MICROBIAL LIG A N D
S................................................................................................81
3. THE ROLE OF INFLAMMASOME AND PROTEASES IN IL-36 EXP RE SSIO N
.......................
82
4. CROSSTALK BETWEEN IL-36 AND LXR S IG N A LIN G
.......................................................83
5. ROLE O F IL-36/LXR AXIS IN CHOLESTEROL METABOLISM AND HOST DEFENSE
.............
84
6. OUTLOOK AND FUTURE
DIRECTION..................................................................................86
REFERENCES...................................................................................................................
88
ACKNOWLEDGEMENTS................................................................................................107
COPYRIGHT
PERMISSION.............................................................................................108
SELBSTAENDIGKEITSERKLAERUNG.............................................................................109
ABBREVIATIONS............................................................................................................
110
APPENDICES...................................................................................................................114
1. M
ATERIALS......................................................................................................................114
1.1.
ANTIBODIES.............................................................................................................
114
1.2. BUFFERS AND
MEDIA.................................................................................................115
1.3.
REAGENTS..............................................................................................................
115
1.4. COMMERCIAL
KITS....................................................................................................
118
1.5.
PRIMERS..................................................................................................................118
1.6. PLASTIC
WARES.............................................................................................
120
1.7. INSTRUMENTS............................. 121
1.8.
SOFTWARE.................................................................................................................122
1.9.
SUPPLIERS................................................................................................................122
2. PUBLICATIONS AND SCIENTIFIC
MEETINGS....................................................................125
2.1.
PUBLICATIONS...........................................................................................................125
2.2. ORAL
PRESENTATIONS................................................................................................
125
2.3. POSTER
PRESENTATIONS.............................................................................................
125
3. CURRICULUM
VITAE.......................................................................................................
126
|
any_adam_object | 1 |
author | Ahsan, Fadhil 1985- |
author_GND | (DE-588)1137384514 |
author_facet | Ahsan, Fadhil 1985- |
author_role | aut |
author_sort | Ahsan, Fadhil 1985- |
author_variant | f a fa |
building | Verbundindex |
bvnumber | BV044426105 |
classification_rvk | YE 1604 |
ctrlnum | (OCoLC)1013468798 (DE-599)BVBBV044426105 |
discipline | Medizin |
format | Thesis Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01375nam a2200301 c 4500</leader><controlfield tag="001">BV044426105</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20220628 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">170726s2017 a||| m||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1013468798</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044426105</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-11</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YE 1604</subfield><subfield code="0">(DE-625)153370:12910</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ahsan, Fadhil</subfield><subfield code="d">1985-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1137384514</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">On the role of interleukin 36 in host defense against Mycobacterium tuberculosis</subfield><subfield code="c">von Fadhil Ahsan</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">127 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Humboldt-Universität zu Berlin</subfield><subfield code="d">2017</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Reproduziert als</subfield><subfield code="a">Ahsan, Fadhil</subfield><subfield code="t">On the role of interleukin 36 in host defense against Mycobacterium tuberculosis</subfield><subfield code="d">Ketsch bei Mannheim : Mikroform Dissertation, 2017</subfield><subfield code="h">2 Mikrofiches</subfield><subfield code="w">(DE-604)BV044868753</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029827593&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029827593</subfield></datafield></record></collection> |
genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
genre_facet | Hochschulschrift |
id | DE-604.BV044426105 |
illustrated | Illustrated |
indexdate | 2024-07-10T07:52:38Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029827593 |
oclc_num | 1013468798 |
open_access_boolean | |
owner | DE-11 |
owner_facet | DE-11 |
physical | 127 Seiten Illustrationen, Diagramme |
publishDate | 2017 |
publishDateSearch | 2017 |
publishDateSort | 2017 |
record_format | marc |
spelling | Ahsan, Fadhil 1985- Verfasser (DE-588)1137384514 aut On the role of interleukin 36 in host defense against Mycobacterium tuberculosis von Fadhil Ahsan Berlin 2017 127 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier Dissertation Humboldt-Universität zu Berlin 2017 (DE-588)4113937-9 Hochschulschrift gnd-content Reproduziert als Ahsan, Fadhil On the role of interleukin 36 in host defense against Mycobacterium tuberculosis Ketsch bei Mannheim : Mikroform Dissertation, 2017 2 Mikrofiches (DE-604)BV044868753 DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029827593&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Ahsan, Fadhil 1985- On the role of interleukin 36 in host defense against Mycobacterium tuberculosis |
subject_GND | (DE-588)4113937-9 |
title | On the role of interleukin 36 in host defense against Mycobacterium tuberculosis |
title_auth | On the role of interleukin 36 in host defense against Mycobacterium tuberculosis |
title_exact_search | On the role of interleukin 36 in host defense against Mycobacterium tuberculosis |
title_full | On the role of interleukin 36 in host defense against Mycobacterium tuberculosis von Fadhil Ahsan |
title_fullStr | On the role of interleukin 36 in host defense against Mycobacterium tuberculosis von Fadhil Ahsan |
title_full_unstemmed | On the role of interleukin 36 in host defense against Mycobacterium tuberculosis von Fadhil Ahsan |
title_short | On the role of interleukin 36 in host defense against Mycobacterium tuberculosis |
title_sort | on the role of interleukin 36 in host defense against mycobacterium tuberculosis |
topic_facet | Hochschulschrift |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029827593&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT ahsanfadhil ontheroleofinterleukin36inhostdefenseagainstmycobacteriumtuberculosis |